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ABSTRACT
Hypoxemia is the most common cause for hospitalization in COVID-19 patients. Acute hypoxemic respiratory failure or
acute respiratory distress syndrome (ARDS) is the most common complication in COVID-19 patients. Close monitoring of
respiratory  decompensation  is  essential.  Supplemental  oxygen,  high  flow  nasal  canula,  non-invasive  ventilation  and
endotracheal intubation are the most commonly suggested methods to improve oxygenation. Early intubation with pre-
oxygenation,  modified  rapid  sequence  intubation  and  intubation  using  a  video  laryngoscope  has  been  advised  as  a
strategy  including  lung  protective  ventilation,  prone  position  ventilation,  adequate  sedation  and  extracorporeal
membrane oxygenation. Strict personal precautions and challenges related to airway management has been currently
studied. The authors summarize here the issues of mechanical ventilation and some strategies to resolve them.
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Clinical spectrum of COVID-19 patients revolves around asymp-
tomatic carriers, upper respiratory tract infections, pneumonia,
heart  failure,  myocarditis,  coagulopathy  and  severe  forms  of
ARDS.  Organ  dysfunction  including  injury  to  heart,  liver  and
kidney is common in the critically ill patients.2 Patients presented
with dyspnea, tachypnea, desaturation with oxygen saturation
less  than  90%,  partial  pressure  (Pa02)  to  fraction  of  inspired
oxygen (FI02) less than 300 mmHg and lung infiltration more than
50% within 48 hours.2 It was observed that relatively asympto-
matic hypoxemia (‘silent hypoxemia’) may be responsible for the
rapid deterioration and gives a false sense of wellbeing when
oxygen  debt  is  been  asymptomatically  increasing  in  COVID
patients. 
Endotracheal intubation was performed in 2.3% of 1099 COVID-19
patients in China1-2 during the outbreak. Patients with cardiopul-
monary arrest and acute respiratory failure due to COVID-19 were
intubated empirically in particular with those patients showing no
improvement with non-invasive ventilation, persistent respira-
tory distress and poor oxygenation (PaO2 to FIO2 ratio less than
150 mmHg) after 2-hours of high-flow oxygen therapy or noninva-
sive ventilation.3 There is no supporting evidence towards early
intubation  could  save  more  lives  however  many  authorities
including American Heart Association, are suggesting it.3
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Studies showed that delayed decision for intubation was related
to adverse outcomes.3 It should be used as a ‘salvage therapy’
when  oxygenation  was  declining.  The  most  recent  report
showed that, among the 22 ICU patients who were intubated, 19
(86%) of them died.3  Shoemaker et al.’s work highlights the
importance of timely reduction of oxygen debt using effective
oxygenation and ventilation therapies. 
Cross infection among healthcare workers were there in the
early outbreak when self-protection was not much established.
Transmission mechanics are still unknown. Withholding intuba-
tion may outweigh the risk of cross infection. HCW should wear
personal protection equipment (PPE) strictly. Efficient educa-
tion should be provided for donning such as hair cover, fit-tested
N95 respirator, water proof gown, double gloving, eye and face
shield, and water proof shoe covers.4  An experienced assistant
should be there to check for donning and doffing process and
provide feedback. Details for doffing process were explained
including hand hygiene, eye and face shield removal,  gown
removal, outer glove removal, shoe cover removal, inner glove
removal, hand hygiene, N95 respirator or equivalent removal,
and hair cover removal.4 A shower and the use of oral, nasal, and
external auditory canal disinfectants are recommended after
the removal of personal protective equipment.
When COVID-19 patient requires intubation, they have no respi-
ratory  reserve  with  exhausted  compensatory  mechanisms.
With  very  low  oxygen  saturation  with  loss  of  breathing  as
common  presentation,  a  careful  airway  management  plan
should  be  made.4-6  PPE  could  make  the  intubation  process
difficulty and with psychological stress of cross infection could
make an easy intubation difficult.
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Preparation includes oxygen, an assistant (helper),  monitor,
suction,  machine  (ventilator),  airway  materials,  intravenous
access and medications (drugs) as acronym OH–MS MAID. With
one-time use disposable supplies, an efficient airway evalua-
tion should be initiated before intubation. Two single-use filters
should be placed in the inhalation and exhalation breathing
circuits. Bacterial filters had been used for Influenza in the past
and were observed to be capable of preventing the infection.5
Well-fitted facemask should be used for pre-oxygenation. Non-
invasive ventilation should be used with 100% Fi02 to maximize
oxygenation. These measures yet need to show promise due to
gap  in  improved  oxygenation  and  unpredictable  outcomes.
Although the aerosol-generating potential of noninvasive venti-
lation is a potential concern to some providers,6 it is being widely
used amid this outbreak.
Mechanical  ventilation  includes  low tidal  volume ventilation
(4–8 mL/kg of predicted body weight), targeting plateau pres-
sures of <30 cm H2O, conservative fluid strategy, a higher posi-
tive end-expiratory pressure (PEEP) strategy and prone ventila-
tion  for  12  to  16  hours  per  day.4-6  Neuromuscular  blocking
agents are recommended to facilitate protective lung venti-
lation, persistent ventilator desynchrony, deep sedation, prone
ventilation, or persistently high plateau pressures.4-6 Further
recommendations  include  head  up  positioning  (30-45°)  to
improve oxygenation and reduce risk of ventilator associated
pneumonia.
Indications for early intubation has been recommended, based
on  early  COVID-19  experience  in  China.1-4  Some  patients
progress to refractory hypoxaemia rapidly, and an awareness
that preparation for intubation takes longer given the need for
airborne/contact  precautions.  However,  reports  from  the
COVID-19  pandemic  suggest  that  some  patients  who  have
severe hypoxaemia can avoid intubation if they are otherwise
stable.4-6 Pre-oxygenation should involve a tight-fitting mask.
Patients refractory to pre-oxygenation (e.g. unable to achieve
SpO2 >90-95%) likely have “shunt” physiology and may require
continuous positive pressure ventilation for preoxygenation.
Risk of viral transmission is avoided further through the use of
viral filter on ventilators, rapid sequence induction with avoi-
dance of bag mask ventilation (unless required for re-oxygena-
tion), avoid cricoid pressure (may stimulate cough / vomiting
and  worsen  view),  routine  use  of  video-laryngoscopy  and
avoiding auscultating the chest post-intubation.
Modified rapid sequence intubation with agents such as Mida-
zolam 1 to 2 mg for anxious patients, lidocaine, 1.5 mg/Kg for
cough suppression, etomidate (0.2 to 0.3 mg/Kg) for patients
with hemodynamic instability or propofol (1 to 1.5 mg/Kg) for
stable  patients.  Fentanyl  (50  to  100  mcg)  may  be  used  to
suppress laryngeal reflexes and optimize the intubation condi-
tion.5-6 Gentle airway manipulation is warranted. It is prudent to
use video laryngoscopy rather than direct laryngoscopy for intu-
bation to minimize the risk of cross infection. Same precautions
should be considered during extubation.
Due  to  lack  of  guidelines,  we  are  adopting  ARDS  guidelines
already established for severe hypoxic patients.1-5  The widely
used practice after lung recruitment maneuvers, is to set PEEP at
20 cm H2O and titrate down in a decrement of 2 to 3 cm H2O. No
mode  of  ventilation  has  been  suggested  to  be  superior  to
others.3  Awake prone ventilation or mechanical ventilation in
the prone position improves oxygenation and lung recruitment.5
Further precaution could be taken for reduction of aerosol gener-
ation  post-intubation  with  endotracheal  tube  cuff  pressure
checks, in-line suction and tight circuit connections.4-6
It is appropriate to be conservative with intravenous fluids in
patients with severe lung injury if there are no signs of tissue
hypoperfusion.2  Early  dexamethasone  administration  may
reduce overall mortality and mechanical ventilation duration in
ARDS  patients.5  Extracorporeal  membrane  oxygenation
showed promise in selected patients and a review suggested
mortality reduction in patients with ARDS hence can be used as
a salvage options in severe hypoxemia.2-6  With acute refractory
hypoxemia, timely intubation is superior to decrease oxygen
debt.
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